Information for patients, public and healthcare professionals
Similar Posts
Good clinical practice for clinical trials
How to show the MHRA you’re meeting good clinical practice (GCP) standards and what to expect from an inspection.
MHRA Takes Over Chair of International Access Consortium for 2026
The Access Consortium — comprising regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland — works together to streamline regulatory processes, support innovation and improve global public health outcomes.
Keep the warmth, lose the risk: MHRA and National Fire Chiefs Council issue winter emollient safety warning
As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the public to be aware of fire risks linked to emollient skin creams.
Submission and assessment timetables for innovative medicines applications
Guidance on the deadlines for initial and response submissions.
Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets, Wockhardt UK Ltd, EL(25)A/31
Wockhardt UK Limited is recalling a batch as a precautionary measure following the identification of a dissolution failure during stability testing.
Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04
Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
